Thymosin-α-1 plasma levels measured after acute SARS-CoV-2 infection are associated with the severity of infection
Thymalfasin, the synthetic form of Thymosin-α-1 (Tα1), which is a thymic peptide hormone with immunomodulatory properties, has been used in the treatment of severe cases of COVID-19, with inconclusive results. Plasma concentrations of Tα1 in COVID-19 patients have never been measured, nor have they been linked to t...